Acura receives $300K in new loans from related party; warns of possible shutdown by mid-Sept 2025

ACURA PHARMACEUTICALS, INC

New loans of $100K each on Aug 1, Aug 15, and Sep 3 from AD Pharma, which owns ~65% of ACUR common stock, bringing total principal to $8.694M.
Loan bears interest at 5.25%; accrued interest ~$795K as of Sep 3; default rate is 7.5%.
Company says without additional financing by mid-September 2025 it may furlough or lay off employees, terminate operations, or seek bankruptcy protection.
Failure to secure funding could result in complete loss of shareholder value, per filing.

item 1.01item 2.01item 2.03item 9.01

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.